HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Roles of immunohistochemistry and detection of SYT-SSX fusion gene in diagnosis of synovial sarcoma].

AbstractOBJECTIVE:
To assess the diagnostic values of immunohistochemistry and SYT-SSX fusion gene detection for synovial sarcoma.
METHODS:
Based on clinical features, histological and immunohistochemical profiles, 195 cases of tumors were divided into three diagnostic categories: definitive synovial sarcoma, probable synovial sarcoma and possible synovial sarcoma. RT-PCR Detection of the SYT-SSX fusion gene was performed using paraffin embedded tissue samples. Comparison between RT-PCR and immunohistochemistry results was carried out and their diagnostic value was evaluated.
RESULTS:
There were 62 (31.8%) definite synovial sarcomas, 49 (25.1%) probable synovial sarcomas and 84 cases (43.1%) possible synovial sarcomas. SYT-SSX fusion gene was detected in 140 (78.2%) cases overall, including 94.7% (54/57) definite synovial sarcomas, 86.0% (37/43) probable synovial sarcomas and 62.0% (49/79) possible synovial sarcomas. In tumors in the certain and probable synovial sarcoma categories, the positive rates of epithelial membrane antigen (EMA) were significantly higher in the SYT-SSX positive cases than SYT-SSX-negative cases (P = 0.022, P = 0.010, respectively). EMA was positively correlated with the presence of SYT-SSX (r(s) = 0.431, P = 0.001, r(s) = 0.463, P = 0.002, respectively). However, such a correlation was not seen in cytokeratin (CK), vimentin or S-100 protein immunostains (P > 0.05). In tumors of possible synovial sarcoma category, there were no significant differences of CK, EMA, vimentin or S-100 protein between SYT-SSX-positive and SYT-SSX-negative tumors.
CONCLUSIONS:
SYT-SSX fusion gene detection is not needed when the conventional approaches are diagnostic. EMA positivity has a similar diagnostic value to that of SYT-SSX by RT-PCR for tumors in the probable synovial sarcoma category. However, detection of SYT-SSX is very important for diagnosis of the tumors in the category of possible synovial sarcoma.
AuthorsYan Sun, Bao-cun Sun, Xiu-lan Zhao, Jian Wang, Jing Chen, Xiao-qing Li, Yu-mei Feng, Zhi-wei Fang, Xi-shan Hao
JournalZhonghua bing li xue za zhi = Chinese journal of pathology (Zhonghua Bing Li Xue Za Zhi) Vol. 36 Issue 7 Pg. 480-4 (Jul 2007) ISSN: 0529-5807 [Print] China
PMID17845763 (Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers, Tumor
  • Mucin-1
  • Oncogene Proteins, Fusion
  • S100 Proteins
  • SYT-SSX fusion protein
  • Vimentin
  • Keratins
Topics
  • Adolescent
  • Adult
  • Aged
  • Biomarkers, Tumor (metabolism)
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Immunohistochemistry
  • Keratins (metabolism)
  • Male
  • Middle Aged
  • Mucin-1 (metabolism)
  • Oncogene Proteins, Fusion (metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • S100 Proteins (metabolism)
  • Sarcoma, Synovial (diagnosis, metabolism, pathology)
  • Soft Tissue Neoplasms (diagnosis, metabolism, pathology)
  • Vimentin (metabolism)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: